Fang Liu
- Infectious Diseases top 0.5%
- COVID-19 Clinical Research Studies 18
- SARS-CoV-2 and COVID-19 Research 12
- Neurology top 0.5%
- Long-Term Effects of COVID-19 8
- Internal Medicine top 2%
- Epidemiology top 2%
- Liver Disease Diagnosis and Treatment 32
- Hepatitis B Virus Studies 8
- Sepsis Diagnosis and Treatment 7
-
- Liver Disease and Transplantation 8
-
- Lipid metabolism and disorders 8
- Co-authors
- Huan HanXinghui LiuRui LiuLan YangJie LiChengliang ZhuXiang ZhouLi Lin
- Journals
- SHILAP Revista de lepidopterología (2 papers)Blood (1 paper)Hepatology (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Fang Liu
144 papers receiving 5.3k citations
Hit Papers
Peers
Comparison fields: 5 of 159
- Infectious Diseases 2.8k
- Neurology 1.6k
- Internal Medicine 216
- Critical Care and Intensive Care Medicine 218
- Epidemiology 1.2k
Countries citing papers authored by Fang Liu
This map shows the geographic impact of Fang Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fang Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fang Liu more than expected).
Fields of papers citing papers by Fang Liu
This network shows the impact of papers produced by Fang Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fang Liu. The network helps show where Fang Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fang Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 11 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 2 | |
| 8 | 2022 | 2 | |
| 9 | 2022 | 2 | |
| 10 | 2022 | 1 | |
| 11 | 2022 | 18 | |
| 12 | 2021 | 6 | |
| 13 | 2021 | 4 | |
| 14 | Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictorsbreakdown → | 2020 | 830 |
| 15 | 2020 | 1 | |
| 16 | 2019 | 6 | |
| 17 | 2018 | 14 | |
| 18 | 2015 | 2 | |
| 19 | Role of Cyfra21-1 Detection in Evaluation of Cervical Cancer New Adjuvant Chemotherapy | 2010 | 1 |
| 20 | 2010 | 13 |
About Fang Liu
Fang Liu is a scholar working on Hepatology, Infectious Diseases and Epidemiology, having authored 156 papers that have together received 5.4k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (32 papers), COVID-19 Clinical Research Studies (18 papers), SARS-CoV-2 and COVID-19 Research (12 papers), Hepatitis B Virus Studies (8 papers), Long-Term Effects of COVID-19 (8 papers), Liver Disease and Transplantation (8 papers), Lipid metabolism and disorders (8 papers) and Sepsis Diagnosis and Treatment (7 papers). The work is most often cited by research in Infectious Diseases (2.8k citations), Neurology (1.6k citations) and Internal Medicine (216 citations). Fang Liu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Huan Han, Xinghui Liu, Rui Liu, Lan Yang, Jie Li, Chengliang Zhu, Xiang Zhou, Li Lin, Juan Wu and Bixi Li. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.